APixaban vs. PhenpRocoumon in Patients With ACS and AF: APPROACH-ACS-AF
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 403 participants.
Also called NCT02789917
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 403 participants
- Sponsor
- Registry
-
NCT02789917
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Germany
- Registry status
- Completed
Technical summary
Registry record NCT02789917. Randomized; no masking; primary purpose treatment. Start 2016-06 (registry gives no type); primary completion 2020-08 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- APixaban vs. PhenpRocoumon in Patients With ACS and AF: APPROACH-ACS-AF
- Acronym
- APPROACH
- Condition
- Acute Coronary Syndrome
- Condition
- Atrial Fibrillation
- Condition
- Coronary Artery Disease
- Intervention (Other)
- Dual Therapy
- Intervention (Other)
- Triple Therapy
- Lead sponsor
- LMU Klinikum
- Collaborator
- Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)
- Collaborator
- Technical University of Munich
- Collaborator
- Helmholtz Zentrum München
- Collaborator
- University of Göttingen
- Collaborator
- University of München
- Collaborator
- University Medicine Greifswald
Record details
- Record id
cardio:ct-nct02789917- Content hash
0983c14e858e9a0161ce88407b18d04f1ceb0903bb35c9f355d6e54291cf2a66